CERo Therapeutics Holdings - Warrants (13/02/2029) Net Income

CERo Therapeutics Holdings - Warrants (13/02/2029) (CEROW) currently reports a net income of $-130M as of June 2026. That compares with $-17M in the prior-year period — down 653.0% year over year. That is below the sector sector average of $98M. Use the charts on this page to explore CERo Therapeutics Holdings - Warrants (13/02/2029)'s net income history and peer comparisons.

CERo Therapeutics Holdings - Warrants (13/02/2029)'s net income decreased from $-17M to $-130M — a 653.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

CERo Therapeutics Holdings - Warrants (13/02/2029)'s net income of $-130M is lower than the its sector sector average of $98M. That is roughly 230.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

CERo Therapeutics Holdings - Warrants (13/02/2029) reported $-130M in net income as of June 2026. That compares with $-17M in the prior-year period — down 653.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net income of $-130M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $98M. From there, open related valuation or income-statement pages for CERo Therapeutics Holdings - Warrants (13/02/2029), and consider following CEROW for alerts when major investors trade the stock.